Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals
MAP
1 other identifier
interventional
156
1 country
1
Brief Summary
We hypothesized that providing physicians treating with HIV disease, at the time of a routine outpatient visit, with a detailed report describing patients' adherence with HIV antiretroviral medications, would improve the quality of the physician-patient interaction, and also patients' subsequent adherence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2002
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2002
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2005
CompletedFirst Submitted
Initial submission to the registry
March 26, 2009
CompletedFirst Posted
Study publicly available on registry
March 27, 2009
CompletedJanuary 11, 2017
March 1, 2009
2.2 years
March 26, 2009
January 10, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Antiretroviral medication adherence as assessed by electronic pill cap monitoring.
6 months
Secondary Outcomes (1)
Self-reported medication adherence
6 months
Study Arms (2)
Received report
ACTIVE COMPARATORRoutine care
PLACEBO COMPARATORPatients receive usual, routine, care.
Interventions
During the intervention phase, the data collected at the study visit were summarized in a 3-page report that was given to the provider before each intervention visit. The report included data on self-reported adherence, MEMS adherence, reminder use, beliefs about ART, reasons for missed doses, alcohol and drug use, and depression.
Eligibility Criteria
You may qualify if:
- on ART
- willing to use MEMS cap
- speaks and reads English
- detectable viral loads
You may not qualify if:
- uses a pill box
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tufts Medical Center
Boston, Massachusetts, 02111, United States
Related Publications (2)
Lu M, Safren SA, Skolnik PR, Rogers WH, Coady W, Hardy H, Wilson IB. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav. 2008 Jan;12(1):86-94. doi: 10.1007/s10461-007-9261-4. Epub 2007 Jun 19.
PMID: 17577653BACKGROUNDVranceanu AM, Safren S, Cowan J, Ring D. The development of the negative pain thoughts questionnaire. Pain Pract. 2008 Sep-Oct;8(5):337-41. doi: 10.1111/j.1533-2500.2008.00213.x. Epub 2008 May 23.
PMID: 18503620BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ira B. Wilson, MD
Tufts Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- NIH
Study Record Dates
First Submitted
March 26, 2009
First Posted
March 27, 2009
Study Start
November 1, 2002
Primary Completion
January 1, 2005
Study Completion
February 1, 2005
Last Updated
January 11, 2017
Record last verified: 2009-03